Ascending Single-Dose Of The Safety, Tolerability, And Pharmacokinetics Of Bosutinib Administered Orally With Multiple Doses Of Ketoconazole To Healthy Adult Subjects.
Interventional
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator)
Safety based on adverse events monitoring, physical examinations, vital sign evaluations, 12-lead ECGs and routine laboratory tests.
5 weeks
Yes
Medical Monitor
Study Director
Wyeth is now a wholly owned subsidiary of Pfizer
Netherlands: Independent Ethics Committee
3160A4-1114
NCT00777530
April 2008
August 2008
Name | Location |
---|